Vildagliptin 50mg + Pioglitazone HCl 15mg is a potent combination oral antidiabetic medication designed to manage type 2 diabetes mellitus effectively. Vildagliptin, a DPP-4 inhibitor, enhances the body's natural incretin hormones, stimulating insulin secretion and reducing glucagon levels in a glucose-dependent manner. Pioglitazone HCl, a thiazolidinedione, improves insulin sensitivity in peripheral tissues and helps regulate blood glucose levels. Together, this combination offers better glycemic control than monotherapy, reducing both fasting and postprandial blood sugar levels. This medicine is suitable for patients who require dual-action therapy to maintain stable blood glucose levels and minimize long-term diabetic complications.
